Product Information
PERAMPANEL 12 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $20.1765 per EA under NDC 00480706856. Its NADAC has been published 32 times since Nov 19, 2025.
Strength
12 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480706856
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PERAMPANELApproval Type
Generic (ANDA)
FDA Application
ANDA209801On Market Since
5/29/2025
Pharmacological Classes
Price Statistics
The NADAC for PERAMPANEL 12 MG TABLET has been published 32 times since Nov 19, 2025, and over the history we have for it it has declined 35.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.1765 per EA |
|---|---|
| All-time high | $31.9208 (Mar 11, 2026) |
| All-time low | $20.1765 (Jun 17, 2026) |
| 52-week high | $31.9208 |
| 52-week low | $20.1765 |
| Median price | $31.4326 |
| Average price | $29.4011 |
| Largest weekly change | -15.0% (Jun 17, 2026) |
| Weeks tracked | 32 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PERAMPANEL 12 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PERAMPANEL 12 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $20.1765 per EA (NDC 00480706856), effective Jun 24, 2026.
How has the price of PERAMPANEL 12 MG TABLET changed over time?
Over the history we have for it, the NADAC for PERAMPANEL 12 MG TABLET has declined 35.8%. It has been tracked across 32 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for PERAMPANEL 12 MG TABLET?
Since Nov 19, 2025, the NADAC for PERAMPANEL 12 MG TABLET has ranged from a low of $20.1765 (Jun 17, 2026) to a high of $31.9208 (Mar 11, 2026), with a median of $31.4326 per EA.
Are there cheaper alternatives to PERAMPANEL 12 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as PERAMPANEL 12 MG TABLET, but none are currently priced below it.
Who manufactures PERAMPANEL 12 MG TABLET?
PERAMPANEL 12 MG TABLET (NDC 00480706856) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification